Home/Filings/4/0001127602-12-010517
4//SEC Filing

Avellone Joseph 4

Accession 0001127602-12-010517

CIK 0000799729other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 2:55 PM ET

Size

22.5 KB

Accession

0001127602-12-010517

Insider Transaction Report

Form 4
Period: 2012-03-09
Avellone Joseph
Corporate VP CRS
Transactions
  • Exercise/Conversion

    Common Stock

    2012-03-09$21.97/sh+5,075$111,49826,775 total
  • Exercise/Conversion

    Common Stock

    2012-03-09$13.00/sh+12,500$162,50053,225 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-03-0910,9630 total
    Exercise: $20.01Exp: 2015-05-24Common Stock (10,963 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-03-096,2506,250 total
    Exercise: $9.12Exp: 2017-03-20Common Stock (6,250 underlying)
  • Exercise/Conversion

    Common Stock

    2012-03-09$20.01/sh+10,963$219,37037,738 total
  • Exercise/Conversion

    Common Stock

    2012-03-09$9.12/sh+6,250$57,00059,475 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-03-095,07515,225 total
    Exercise: $21.97Exp: 2018-09-15Common Stock (5,075 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-03-092,9870 total
    Exercise: $23.06Exp: 2015-12-20Common Stock (2,987 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-03-0912,50012,500 total
    Exercise: $13.00Exp: 2017-12-09Common Stock (12,500 underlying)
  • Exercise/Conversion

    Common Stock

    2012-03-09$23.06/sh+2,987$68,88040,725 total
  • Sale

    Common Stock

    2012-03-09$25.22/sh37,775$952,68621,700 total
Footnotes (3)
  • [F1]This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $24.99- $25.45. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
  • [F2]Options become exercisable in 4 annual increments of 25% of the total grant, commencing on the first anniversary of the date of grant.
  • [F3]Currently exercisable

Issuer

PAREXEL INTERNATIONAL CORP

CIK 0000799729

Entity typeother

Related Parties

1
  • filerCIK 0001499098

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 2:55 PM ET
Size
22.5 KB